Advances in Hematological Malignancies
Recent decades have witnessed remarkable progress in the area of hematological malignancies. Novel therapies such as targeted agents, immunotherapies, and gene editing are transforming the outlook for patients with blood cancers. Ongoing investigations continue to explore these innovative approaches, offering potential for more successful treatment